IP Library › Granted Patent US 10,206,981
Granted Patent B2
US 10,206,981 · App. 15/354,139 · Granted Feb 19, 2019

Anti-inflammatory peptides and composition comprising the same

Inventors: Sang Jae Kim (Seoul, KR); Kyung Hee Kim (Seongnam-si, KR); Kyu-Yong Lee (Seongnam-si, KR); Seong-Ho Koh (Seongnam-si, KR); Hyun-Hee Park (Seongnam-si, KR); Sung Jin Huh (Seongnam-si, KR); Woo Jin Lee (Seongnam-si, KR); Bum Joon Kim (Seongnam-si, KR)
Assignee: GemVax & KAEL Co., Ltd.
A61K38/45A23L33/18A61K8/64A61Q19/00C07K7/08C07K14/4703C12N9/0069C12N9/0083C12Y113/11C12Y114/99001C12Y207/07049A23V2002/00A61K38/00Y02A50/385Y02A50/411Y02A50/422
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,206,981
App. No.
15/354,139
Granted
Feb 19, 2019
Kind
B2
Abstract

A peptide with anti-inflammatory activity is described, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising those peptides can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Claims (12)

1. An anti-inflammatory composition comprising an isolated peptide 10 amino acids in length having the amino acid sequence of SEQ ID NO: 146 as an active ingredient.

2. The anti-inflammatory composition according to claim 1 , which is a cosmetic composition for improving skin inflammation.

3. An anti-inflammatory composition of claim 1 , which is a pharmaceutical composition.

4. The anti-inflammatory composition of claim 1 , comprising 0.1 μg/mg to 1 mg/mg of the isolated peptide.

5. The anti-inflammatory composition of claim 1 , wherein the composition is a pharmaceutical composition formulated for oral, rectal, transdermal, intravenous, intramuscular, intraperitoneal, intramedullary, epidural, or subcutaneous administration in a subject.

6. The anti-inflammatory composition of claim 5 , wherein the subject is selected from the group consisting of human, dog, chicken, pig, cow, sheep, guinea pig, and monkey.

7. The anti-inflammatory composition of claim 5 , wherein the subject is human.

8. The anti-inflammatory composition of claim 1 , wherein the composition is a form selected from the group consisting of a tablet, a pill, a soft capsule, a hard capsule, a granule, a powder, a solution, and a emulsion.

9. The anti-inflammatory composition of claim 1 , wherein the composition is a form selected from the group consisting of a drip, a lotion, an ointment, a gel, a cream, a suspension, an emulsion, a suppository, a patch, and a spray.

10. The anti-inflammatory composition of claim 1 , wherein the composition further comprises one or more of a diluent, an excipient, a lubricant, a binder, a disintegrant, a buffer, a dispersant, a surfactant, a coloring agent, an aromatic, or a sweetener.

11. The anti-inflammatory composition of claim 1 , which consists of an isolated peptide 10 amino acids in length having the amino acid sequence of SEQ ID NO: 146.

12. The anti-inflammatory composition of claim 1 for treatment of Churg strauss syndrome, rheumatoid arthritis, or Sjogren's syndrome.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2023
From: GEMVAX & KAEL CO. LTD.
To: GEMVAX & KAEL CO. LTD.; KIM, SANG JAE
Reel/Frame 065471/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2016
From: KIM, SANG JAE
To: GEMVAX & KAEL CO., LTD.
Reel/Frame 040398/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2016
From: KIM, KYUNG HEE; LEE, KYU-YONG; KOH, SEONG-HO; PARK, HYUN-HEE; HUH, SUNG JIN; LEE, WOO JIN; KIM, BUM JOON
To: GEMVAX & KAEL CO., LTD.
Reel/Frame 040398/0113 →
Priority Claims (5)
KR 10-2012-0050529 · May 11, 2012 · national
KR 10-2012-0050533 · May 11, 2012 · national
KR 10-2012-0071989 · Jul 2, 2012 · national
KR 10-2012-0104144 · Sep 19, 2012 · national
KR 10-2012-0104207 · Sep 19, 2012 · national
Continuity (2)
Division 14400321
Related Publication 20170081376A1 · Mar 23, 2017